TABLE 2.
Treatment delivery
ARM A No. of patients |
% |
ARM B No. of patients |
% | P | |
---|---|---|---|---|---|
Induction chemotherapy | |||||
3 cycles | 28 | 53.8 | 24 | 44.4 | 0.33 |
2 cycles | 23 | 44.2 | 27 | 50.0 | 0.55 |
1 cycle | 1 | 1.9 | 3 | 5.6 | 0.33 |
Concomitant chemotherapy | |||||
2 cycles | 15 | 28.8 | 19 | 35.2 | 0.48 |
1 cycle | 26 | 50 | 24 | 44.4 | 0.57 |
Incomplete 1 cycle | 10 | 19.1 | 9 | 16.7 | 0.92 |
No chemotherapy | 1 | 1.9 | 2 | 3.7 | 0.39 |
Radical radiotherapy | |||||
Started radical RT | 50 | 100 | 53 | 98.1 | 0.54 |
Surgical treatment after induction chemotherapy | 0 | 0 | 1 (pulmectomy) | 1.9 | 0.32 |
RT doses >60 Gy | 44 | 84.6 | 47 | 87.0 | 0.72 |
RT doses >56 Gy | 48 | 92.4 | 53 | 98.1 | 0.16 |
| |||||
PARAMETERS OF RADIOTHERAPY | ARM A | ARM B | |||
| |||||
GTV (cm3) | |||||
Median | 123 | 124 | 0.98 | ||
Range | 12–381 | 11–658 | |||
PTV (cm3) | |||||
Median | 619 | 626 | 0.99 | ||
Range | 133–1282 | 210–1428 | |||
V5 (%) | |||||
Median | 64 | 61 | 0.52 | ||
Range | 21–88 | 27–86 | |||
V20 (%) | |||||
Median | 33 | 33 | 0.46 | ||
Range | 12–56 | 20–52 | |||
V20 > 40% | |||||
No. of patients | 12 | 24 | 6 | 12 | 0.12 |
MLD (Gy) | |||||
Median | 20 | 19 | 0.34 | ||
Range | 6–30 | 12–27 | |||
V50oes (%) | |||||
Median | 47 | 42 | 0.06 | ||
Range | 15–82 | 2–68 | |||
MoesD (Gy) | |||||
Median | 35 | 32 | 0.17 | ||
Range | 7–52 | 11–44 |
GTV = gross tumor volume; MoesD = mean esophagus dose in Gy; MLD = mean lung dose in Gy; No. = number; PTV = panning target volume; RT = radiotherapy; V5 = volume of lung receiving at least 5 Gy; V20 = volume of lung receiving at least 20 Gy; V50oes = volume of esophagus receiving at least 50 Gy